SARS-COV-2 MPRO INHIBITOR COMPOUNDS
The invention described herein relates to compounds of Formula (1b):or a salt thereof, wherein R1, R1a, R2, R3 and R5 are defined herein, and their use in the treatment of SARS-CoV-2 and related viruses and disorders associated with SARS-CoV-2.
Saved in:
| Main Authors | , , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
04.07.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The invention described herein relates to compounds of Formula (1b):or a salt thereof, wherein R1, R1a, R2, R3 and R5 are defined herein, and their use in the treatment of SARS-CoV-2 and related viruses and disorders associated with SARS-CoV-2. |
|---|---|
| AbstractList | The invention described herein relates to compounds of Formula (1b):or a salt thereof, wherein R1, R1a, R2, R3 and R5 are defined herein, and their use in the treatment of SARS-CoV-2 and related viruses and disorders associated with SARS-CoV-2. |
| Author | CONGREVE, Miles Stuart MASON, Jonathan Stephen PICKWORTH, Mark DE GRAAF, Chris HIGUERUELO, Alicia Perez CHRISTOPHER, John Andrew |
| Author_xml | – fullname: PICKWORTH, Mark – fullname: DE GRAAF, Chris – fullname: HIGUERUELO, Alicia Perez – fullname: CONGREVE, Miles Stuart – fullname: CHRISTOPHER, John Andrew – fullname: MASON, Jonathan Stephen |
| BookMark | eNrjYmDJy89L5WRQDnYMCtZ19g_TNVLwDQjyV_D08_B08gzxD1Jw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBkYmRobmlsYGjobGxKkCAMlIJWM |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2024217930A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2024217930A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:47:19 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2024217930A13 |
| Notes | Application Number: US202218553596 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240704&DB=EPODOC&CC=US&NR=2024217930A1 |
| ParticipantIDs | epo_espacenet_US2024217930A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20240704 |
| PublicationDateYYYYMMDD | 2024-07-04 |
| PublicationDate_xml | – month: 07 year: 2024 text: 20240704 day: 04 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | HEPTARES THERAPEUTICS LIMITED |
| RelatedCompanies_xml | – name: HEPTARES THERAPEUTICS LIMITED |
| Score | 3.5568607 |
| Snippet | The invention described herein relates to compounds of Formula (1b):or a salt thereof, wherein R1, R1a, R2, R3 and R5 are defined herein, and their use in the... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | SARS-COV-2 MPRO INHIBITOR COMPOUNDS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240704&DB=EPODOC&locale=&CC=US&NR=2024217930A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TCpO-Bbd-UR-KbOlKK7Qp7Tr2NkyXwEDmcBX_vpew6Z72luTg8nm5u9xHAJ4kd6XLeU18n7vEGfQX5B25JrFrlJU9S-ChUvHOaebFlfM2c2ct-NjFwug8oT86OSJSVI303uj7ev3_iBVq38rNM19i0-drNAlCc6sdK_UENz0cBeOchYyalAZVaWaFhlnqMPaHqCsdKUFaZdofT0cqLmW9z1SiczjOEd-quYCWWHXglO7-XuvASbo1eWNxS32bS-iVw6IklE2JZaR5wYwki5NRMmGFQVmasyoLyyvoReMJjQn2Nv-b3Lwq94dmX0Mb1X5xA4ZYCIR4whlI23mRyn5Vc-lL27Vl7cn6FrqHMN0dBt_Dmapqx1OnC-3m61s8IHtt-KNelV9abXnA |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEJ4QNOJNUSOKugmGWyOwD9cDMdCF7Cq73eyDcCN2aRMTg0TW-PedNqCcuDWdZPqcTr_OowD3ktvS5rwgrsttYnU7C_KGWpOYBd6VnZ7ATaXincPI8XPrZWbPKvCxjYXReUJ_dHJElKgC5b3U5_Xq_xHL076V6wf-jlWfz-Os77U36FjBE1x0b9gfxcxjtE1pP0_bUaJpPbUZOwPESgePCApVpv3RdKjiUla7SmV8Aocx8luWp1ARyzrU6PbvtTochRuTNxY30rc-g1Y6SFJC2ZT0jDBOmBFEfjAMMpYYlIUxyyMvPYfWeJRRn2Br87_BzfN0t2vmBVQR9otLMMRCIMURVlea1pNU9quCS1eatikLRxYNaO7jdLWffAc1Pwsn80kQvV7DsSJpJ1SrCdXy61vcoKot-a2eoV8xqHyr |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SARS-COV-2+MPRO+INHIBITOR+COMPOUNDS&rft.inventor=PICKWORTH%2C+Mark&rft.inventor=DE+GRAAF%2C+Chris&rft.inventor=HIGUERUELO%2C+Alicia+Perez&rft.inventor=CONGREVE%2C+Miles+Stuart&rft.inventor=CHRISTOPHER%2C+John+Andrew&rft.inventor=MASON%2C+Jonathan+Stephen&rft.date=2024-07-04&rft.externalDBID=A1&rft.externalDocID=US2024217930A1 |